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Abstract
Background. Metallothioneins (MTs) constitute a family of evolutionary conserved low molecular weight 
proteins with small variations in their amino acid sequences. They play a role in the regulation of trace metals 
metabolism, in the detoxification of heavy metal ions and in mechanisms controlling growth, differentiation 
and proliferation of cells.
Objectives. The aim of this study was to evaluate the human and rabbit MTs purity and characterization 
using advanced analytical approaches. Due to the common use of MT from rabbit liver as a model protein, 
the properties of the rabbit and human MTs were compared.
Material and methods. Capillary electrophoresis (CE), matrix-assisted laser desorption and ionization 
time-of-flight mass spectrometry (MALDI-TOF-MS) and Brdicka reaction were used for human and rabbit 
MTs characterization.
Results. In chip CE analysis, changes in the range of 5–8 kDa corresponding to the MT monomer, as well 
as some peaks of 13–14 kDa corresponding to dimers in both species, were observed. Using MALDI-MS, 
rabbit (MT-2D) and human (MT-1A, MT-1G, MT-1G + Cd and MT-2A) MTs were identified. In the Brdicka 
reaction analysis, a lower concentration of MTs from both organisms coincided with a decrease in the signal 
corresponding to MT level (Cat2). However, human MT gave higher Cat2 peak than the same concentration 
(0.025 mg/mL) of rabbit MT.
Conclusions. The applied methods allowed for the characterization of MTs and gave complementary 
information about MT isoforms. Altered electrochemical activity of human and rabbit MTs, despite the 
same number of –sulfhydryl (−SH) groups, was observed, which may be due to different availability of MT 
cysteinyl groups.
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Introduction
Metallothioneins (MTs) make up a large family of evo-
lutionarily conserved low molecular weight, thermostable 
proteins, found in practically all life forms: in vertebrates, 
invertebrates, fungi, and even in plants. Their sizes range 
from 25 (fungal) to 84 (plant) amino acids.1 A single poly-
peptide chain of mammalian MT is composed of 61–68 
mostly non-aromatic amino acids and contains 20 cys-
teinyl residues in highly conserved locations along the 
peptide chain. High number of cysteines in MTs explains 
their high capacity for binding metal ions through sulf-
hydryl groups, forming metal–thiolate complexes. Thus, 
their main proposed functions were derived from their 
role in the homeostatic control of a number of essential 
metals (copper – Cu, zinc – Zn), in detoxification of toxic 
ones (e.g., cadmium – Cd, mercury – Hg), and in protec-
tive actions against oxidative stress conditions.2–4 This 
known fact forms the basis of MTs being used as possible 
biomarkers for metal exposure.5
Four isoforms of mammalian MT (MT-1, MT-2, MT-
3, and MT-4) have been identified. Isoforms with minor 
differences, such as amino acid residue, have been de-
tected as subgroups of the 2 major isoforms (MT-1 and 
MT-2) and are termed subisoforms. These 2 main groups 
of MT isoforms have been classified according to human 
MT elution order by anionic-exchange chromatography: 
MT-1 and MT-2.6 They are the most widely distributed 
MT isoforms, expressed in many cell types in different 
tissues and organs. They can be induced by the admin-
istration of metals such as Cd, Zn and Cu; by oxidative 
stress; by glucocorticoids; and by cytokines.7 MT-1 and 
MT-2 are present in nearly all tissues and have been iso-
lated from organs such as the liver, kidney and brain. MT-3 
is expressed mostly in nervous tissue8 and MT-4 has been 
detected in epithelial cells.9 Since various subisoforms are 
biosynthesized differentially, they could play a specific 
biological role, but this aspect is still being investigated. 
The interesting properties of MTs are closely related to 
their structure. In addition to slight differences in amino 
acid sequences, MTs exist as a mixture of varying metal-
lic content.5 It is not a simple task to detect and quantify 
MT, also due to its high cysteine content and relatively low 
molecular mass. The characteristics of human MTs are 
not widely described because rabbit MTs are more often 
used in studies as a model protein; thus, it is so valuable 
to compare MTs from these organisms. To analyze MTs, 
many methods can be used that differ in the analytical 
approach, usually based on the metal ions detection, free 
thiol moieties or enzyme-linked immunosorbent assay 
(ELISA). Human and rabbit MTs have previously been 
analyzed by western blot, ELISA, capillary electrophoresis 
(CE), and high-performance liquid chromatography.10–15
Therefore, the purpose of the research was the compre-
hensive characterization of human and rabbit MTs. Mod-
ern electrochemical and advanced analytical approaches 
such as the Brdicka reaction, chip CE and matrix-assisted 
laser desorption and ionization time-of-flight mass spec-
trometry (MALDI-TOF-MS) were used to characterize and 
compare human and rabbit MTs.
Material and methods
Material
All chemicals used were commercially available. Rabbit 
liver MT-2 (M-5392), 2-mercaptoethanol, ammonia solution, 
ammonium bicarbonate, trifluoroacetic acid (TFA), and for-
mic acid were purchased from Sigma–Aldrich (St. Louis, 
USA). Acetonitrile (ACN) and methanol were purchased from 
Fluka (Seelze, Germany). Acidic MALDI matrices α-cyano-
4-hydroxycinnamic acid (HCCA), 2,5-dihydroxobenzoic 
acid (DHB) and peptide calibration standard mixture were 
purchased from Bruker Daltonics (Bremen, Germany). All 
reagents were of the highest available purity. Doubly distilled 
deionized water was used throughout all the experiments.
Preparation of metallothioneins from 
human liver
Isoforms MT-1 and MT-2 were purified from human 
liver earlier at the Department of Biomedical and Envi-
ronmental Analysis, Faculty of Pharmacy with Division 
of Laboratory Medicine, Wroclaw Medical University, Po-
land, and the presence of MTs was confirmed by sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) and western blot.10
Chip capillary electrophoresis
Capillary electrophoresis experiments were performed 
on  an  automated microfluidic Experion electrophore-
sis system (Bio-Rad, Hercules, USA), according to  the 
manufacturer’s instructions and with supplied chemi-
cals (Experion Pro260 analysis kit, Cat. No.  700-7101, 
Bio-Rad). Metallothioneins in a quantity of 4 µL (0.1 or 
0.18  µg/µl) were mixed with 2  µL of  reducing sample 
buffer (30 µL of a nonreducing sample buffer and 1 µL 
of β-mercaptoethanol); after 4 min of boiling, 84 μL of wa-
ter were added. The ladder was also prepared in reducing 
conditions. After the priming of the chip with the gel and 
gel-staining solution in the diluted priming station sample, 
6 µL of the mixture were loaded into the sample wells. 
The Pro260 Ladder included in the kit was used as a stan-
dard. For operation and standard data analysis, Experion 
software v. 3.10 (Bio-Rad) was used.
Mass spectrometry analysis
Mass spectrometry analysis was performed using ma-
trix-assisted laser desorption and ionization time-of-flight 
mass spectrometry (MALDI-TOF-MS). Working standard 
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solutions were prepared daily by diluting the stock solu-
tions. A mixture of peptide calibration standard (Bruker 
Daltonics) was used to calibrate the instrument. All mea-
surements were performed on the UltrafleXtreme MALDI-
TOF/TOF mass spectrometer (Bruker Daltonics) equipped 
with a  laser operating at a wavelength of 355 nm with 
an accelerating voltage of 25 kV, cooled with liquid nitro-
gen, at a maximum energy of 36 µJ with a repetition rate 
of 2000 Hz in reflector-positive ionization mode, and with 
software for data acquisition and processing of mass spec-
tra flexControl v. 3.4 and flexAnalysis v. 2.2. The spectra 
were measured in the range of 0–20,000 mass-to-change 
ratio (m/z). Laser power intensity was set to 5% above the 
threshold, which determines the minimal intensity for 
suitable spectrum; it is set experimentally by measuring 
spectra with increasing laser power intensity. A MALDI 
MTP 384 target plate (polished steel) was used.
Before MT analysis, a cut-off filter (Amicon 3K; Merck 
Millipore, Burlington, USA) for desalinization of the MT 
sample and buffer exchange to water was used. Then, the 
samples were mixed with DHB or HCCA matrix solution 
in 1:1 volume ratio and then 1 µL of the mixture was de-
posited on the target plate (dried-droplet method) and 
dried under atmospheric pressure and ambient tempera-
ture. Saturated solutions of DHB or HCCA were prepared 
in TA30 (30% ACN and 0.1% TFA). Mass spectra were 
typically acquired by averaging 20 subspectra from a total 
of 500 shots of the laser (Smartbeam 2 v. 1_0_38.5; Bruker 
Daltonics).
Differential pulse voltammetry
Differential pulse voltammetry (DPV) measurements 
were performed with a 747 VA Stand instrument con-
nected to a 746 VA Trace Analyzer and a 695 Autosam-
pler (Metrohm, Herisau, Switzerland) using a standard 
cell with 3 electrodes and a cooled sample holder (4°C). 
A hanging mercury drop electrode (HMDE) with a drop 
area of 0.4 mm2 was used as the working electrode. An  
Ag/AgCl/3M KCl was the reference electrode and a glassy 
carbon electrode was the auxiliary electrode. The GPES v. 
4.9 software supplied by EcoChemie (Utrecht, the Nether-
lands) was employed for smoothing and baseline correc-
tion of the raw data. The Brdicka supporting electrolyte 
containing 1 mM Co(NH3)6Cl3 and 1 M ammonia buf-
fer (NH3(aq) + NH4Cl, pH = 9.6) was used. The param-
eters of the measurement were as follows: initial potential 
of −0.7 V, end potential of −1.75 V, modulation time 0.057 s, 
time interval 0.2 s, step potential 2 mV, and modulation 
amplitude −250 mV. All experiments were carried out at 
4°C employing a Julabo F12 thermostat (Julabo Labortech-
nik GmbH, Seelbach, Germany).
Results and discussion
Sequence differences in human  
and rabbit metallothioneins
Most studies concerning mammalian MTs usually as-
sociate MT-1 with MT-2. These 2 isoforms are examined 
as equal peptides, mostly because they are the closest para-
logs that have been found and purified together.16 They are 
commonly referred as MT-1/MT-2. However, the availabil-
ity of transcriptomic and proteomic techniques highlights 
differences in MT-1 and MT-2 that cannot be ignored, 
suggesting some degree of functional differentiation be-
tween these isoforms both within the same species as well 
as between humans and rabbits.
Amino acid sequences of rabbit MT isoforms show differ-
ences when compared to the sequences of human MTs (Fig. 1). 
Human MTs are controlled by 17 genes located on chro-
mosome 16, 10 of which are functional. To date, 10 subiso-
forms of human liver MT-1/2 have been reported (MT-1A, 
MT-1B, MT-1E, MT-1F, MT-1G, MT-1H, MT-1M, MT-1L, 
MT-1X, and MT-2A)2; their amino acid sequences are shown 
in Fig. 1A. Subisoform MT-1G contains 62 amino acids, 
whereas the others display a structure of 61 amino acids.
Rabbit MT genes are located on chromosome 5. Six subi-
soforms of rabbit liver MT-1/2 have been reported so far 
(MT-1A, MT-2A, MT-2B, MT-2C, MT-2D, and MT-2E)17; 
their amino acid sequences are presented in  Fig.  1B. 
Subisoforms MT-2A and MT-2C contain 62 amino acids, 
whereas the others display a structure of 61 amino acids. 
The reasons for the high diversity of MT isoforms and 
their specific functional roles are still unclear. The poten-
tial biological significance of each isoform should not be 
neglected but the analytical techniques available cannot 
easily separate them.18
By ion-exchange chromatography, human MTs were sepa-
rated into 2 charge-separable isoforms, designated as MT 
fractions 1 and 2.17 However, MT fractions from rabbit liver 
obtained with the same ion-exchange chromatography can-
not be separated into MT-1 and MT-2 subfractions. This con-
ventional nomenclature division based on charge differences 
refers to the absence (MT-1) or presence (MT-2) of an aspartic 
acid residue at position 11 or 12 (10 or 11) of the sequence 
(Fig. 1) and it is not based on their global charge.19
Amino acid sequences of 6 rabbit MT isoforms show 
some differences compared to the sequences of human MTs 
(Fig. 1). Owing to the insertion of an additional amino acid at 
position 10, MT-2A and MT-2C sequences have a total chain 
length of 62 amino acids. MT-1G, having the same length 
and the same insertion, has also been identified in human 
liver. The presence of differential expression of MT-1G1 
(with an additional alanine) and MT-1G2 (without addi-
tional alanine) suggests tissue- and cell-specific alterna-
tive splicing for the MT-1G isoform.20 The insertion of the 
alanine residue at position 10 of the sequence relates to the 
location of the connection of exons 1 and 2 of the rabbit 
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MT-2A and 2C gene and human MT-1G gene. The pres-
ence of the additional alanine does not seem to influence 
neither the tertiary structure nor the metal-binding proper-
ties of the protein.17,21 The biological consequence of that 
insertion remains undefined but its presence in more than 
1 species suggests a common mechanism leading to the 
same phenotype.
In rabbit MT-2D and MT-2E, there is a substitution of ar-
ginine (R) residue in position 10/11 (Fig. 1B). The additional 
positive charge may be involved in compensating for the 
net negative charge of the 3-metal-cluster and thus can 
increase the stability of the β-cluster.17
Even minor changes in the sequence of MT may induce 
structural changes that can alter the metal-binding prop-
erties or stability of the 3-metal-cluster. The flexibility 
of the polypeptide chain as well as the charge environment 
of the coordinating sulfur atoms may greatly influence the 
feasibility and stability of the metal-thiolate bonds, and as 
a result, of the final metal–MT complex.
Aras et al. noticed a conserved PKC phosphorylation site 
at serine-32 (S32) of MT, which was important in modu-
lating Zn2+-regulated gene expression.22 It is present in all 
rabbit and human MT isoforms shown in Fig. 1, except hu-
man MT-1B. The presence of cysteine in place of serine can 
change the tertiary structure of the protein as well as change 
the function of the protein dependent on phosphorylation.
Different expression patterns of MT subisoforms are 
observed in various types of human malignancies; this 
fact can be useful in the diagnosis and therapy of tumors.3 
The exact biological significance of the differences in ami-




Capillary electrophoresis is often used to analyze and 
separate MT isoforms from different organisms and tis-
sues.11,23 It can also be used for monitoring MT concentra-
tion in biological samples.23 Křížková et al. were the first 
to propose a chip CE technique for the analysis of MT, i.e., 
of the effect of oxidation on the structure of MT and its 
ability to form aggregates and polymers.24 Unfortunately, 
due to the presence of system peaks, an accurate analysis 
of the MT monomer is difficult.12,25
In this study, changes in the range of 5–8 kDa corre-
sponding to the MT monomer were observed for both hu-
man and rabbit MTs. However, the monomers co-migrated 
with a system peak, which made it difficult to measure 
their correct size. In Fig. 2, the peak obtained for rabbit MT 
shifted to a bigger mass (8.2 kDa) in comparison to human 
MTs (6.0 and 7.7 kDa for human MT-1, and 5.3 and 6.1 
kDa for human MT-2). An additional peak was observed at 
about 23–24 min, which may indicate the presence of 13.4 
and 14.0 kDa oligomers. Peaks corresponding to MT di-
mers were observed both for human and rabbit MTs.
Mass spectrometry analysis
In the majority of MALDI-MS studies, DHB and HCCA 
were the constituents of the matrix used for the appro-
priate determination of MTs.26 In our study, utilization 
of both matrixes resulted in different types of crystals. 
While HCCA produced uniform crystals, DHB produced 
Fig. 1. Comparison of human and rabbit metallothionein (MT) isoforms 1 and 2 sequences (MT-1 and MT-2). Sequence comparison of MT-1/2 from 
human (MT-1A, MT-1B, MT-1E, MT-1F, MT-1G, MT-1H, MT-1M, MT-1L, and MT-1X, MT-2A) and from rabbit (MT-1A, MT-2A, MT-2B, MT-2C, MT-2D, and MT-2E) was 
performed using ClustulX program.37 The sequences were derived from the database SWISS PROT (http://www.expasy.org/sprot/)
* indicates positions which have a single, fully conserved residue; : indicates conservation between groups of strongly similar properties – scoring > 0.5; 
indicates conservation between groups of weakly similar properties – scoring ≤0.5. The red color indicates negative amino acid residues; the color green 
indicates positive amino acid residues; the pink color indicates cysteine residues; the blue color marks alanine – an additional amino acid at position 10; 
substitution of an aspartic acid residue at position 11/12 is indicated by the frame.
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heterogeneous and robust crystals (Fig. 3A). Furthermore, 
DHB exhibited a significant rabbit MT-2 concentration-
dependent increase in observed signal intensity (expressed 
in a.u.), higher when compared to that of HCCA (Fig. 3B). 
The main observed signal for rabbit MT-2 was 6211.07 m/z. 
Moreover, it was estimated that the isolated MT-2 was 
highly pure, because each spectrum showed only 1 peak 
of high intensity for the relevant protein. This peak showed 
a mass similar to rabbit MT-2D (6215.40 m/z).27 The occur-
rence of the MT-2D form has been also observed in MT-2 
from Sigma lots27,28 and in MT-1 sample, as a remaining 
contaminant.28 The size of 12342.11 Da corresponds to the 
MT-2 dimer (Fig. 3C inset).
The DHB was chosen as the most appropriate matrix 
in terms of sensitivity and reproducibility for human MTs; 
at given conditions (20 mg/mL of DHB in 30% ACN and 
1% TFA), homogeneous spots applicable for automated 
MALDI-TOF-MS were formed. Further, to verify the prop-
er isolation of MT-1 and MT-2 from humans, we analyzed 
their mass distribution. The main observed signals for hu-
man MTs (hMTs) shown in Fig. 4 were quasimolecular ions 
assigned as follows: [hMT-1]+ (6145.23 m/z, 6176.46 m/z 
and 6220.12 m/z) (Fig. 4A), and [hMT-2]+ (6066.24 m/z) 
(Fig. 4B). The sizes of 12523.89 Da and 12329.89 Da corre-
spond to MT-1 and MT-2 dimers. The mass spectra of the 
human MT-1 sample yielded a main peak, the most intense 
at 6176.46 Da. Peaks observed in the spectra of these MT-1 
samples can be attributed to potential subisoforms: MT-1A 
(6145.23 m/z), MT-1G (6176.46 m/z) and MT-1G+Cd 
(6240.12 m/z).29,30 The theoretical mass of human MT-2A 
is 6042.16 m/z and our results showed main signals at 
6066.24 m/z, corresponding to [hMT-2A+Na]+.
The exposure of MTs to acidic pH values causes metal 
depletion and unfolding of the protein structure, gener-
ating apothioneins or metal-free forms. Using these ma-
trixes caused the coordinated metals of the proteins to be 
removed, and the peaks obtained should be apothioneins, 
i.e., subisoforms without metal content.
Metallothionein dimers were first detected as transient 
intermediate species during interprotein metal exchange, 
and longer-lived dimers have been isolated that were sta-
bilized by intermolecular disulfide bonds.31 No transient 
intermediate dimers could be detected with mass spec-
trometry. However, a stable dimeric complex of MTs has 
been detected in this work by MALDI-TOF-MS and chip 
CE, and it appears to be stabilized by disulfide bridging. 
Metallothioneins can dimerize through the oxidation 
of their cysteinyl residues to form an interprotein Cys–
Cys dithiol bridge; the experimental mass would decrease 
by 2 Da for every oxidative thiol bridge formation event.
Metallothionein analysis  
using the Brdicka reaction
Metallothionein exhibits significant electrochemical ac-
tivity owing to its high content of sulfhydryl (SH) moieties. 
The method of determining proteins which contain –SH 
groups in an ammonia-buffered cobalt (III) solution was first 
described by Brdička.32 Brdicka reaction is one of the most-
often-used electrochemical methods for MT determination 
Fig. 2. Metallothionein (MT) separation using chip capillary gel electrophoresis (CE). Electropherograms of: A) in red, MT-1 from human liver; in blue, MT-2 
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Fig. 4. Mass spectrum of human metallothionein (MT). Spectrum of MT-1 (A) and MT-2 (B) from human measured by matrix-assisted laser desorption and 
ionization time-of-flight mass spectrometry (MALDI-TOF-MS) with the 2,5-dihydroxybenzoic acid (DHB) matrix in linear positive mode in a mass range 
of 4–16 kDa prepared in TA30 with repetition rate of 2000 Hz
Fig. 3. Mass spectrum of rabbit metallothionein (MT). A) Spectrum of MT-2 from rabbit liver measured by matrix-assisted laser desorption and ionization 
time-of-flight mass spectrometry (MALDI-TOF-MS) with (A.1) α-cyano-4-hydroxycinnamic (HCCA) and (A.2) 2,5-dihydroxybenzoic acid (DHB) matrix.  
B) Graphs of signal intensity of different concentrations of rabbit MT-2 in DHB and HCCA matrices. 1–2 µL of sample/matrix mixture (1:1) deposited on MALDI 
plate and dried at room temperature (dried-droplet method). Analysis by a MALDI-TOF-MS mass spectrometer was performed in linear and reflector mode. 
Dimerization of MT analyzed by MALDI-TOF-MS is shown in the inset of Fig. C) Spectrum of rabbit MT-2 measured by MALDI-TOF-MS with the DHB matrix 
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in biological samples.33 It is based on the reduction of hydro-
gen at the mercury electrode catalyzed by the –SH groups 
in the ammonia-buffered cobalt(III) solution.34
The Brdicka reaction has potential for monitoring the 
differences of various MT isoforms, both rabbit and hu-
man.26 During MT analysis, changes in Cat2 signal (−1.55 V, 
which represents the current response of the MT complex 
with components of the Brdicka electrolyte), Co2+ (−1.25 V) 
and Cat1 (−1.40 V) corresponding to hydrogen evolution 
from the supporting electrolyte catalyzed by the MT were 
observed.35 The presence of the Cat2 peak is closely con-
nected with the quantification of –SH groups occurring 
in the Brdicka solution,36 thus corresponding to the MT 
level. The voltammograms of human and rabbit MT are 
shown in Fig. 5. It can be observed that the character of the 
mentioned MT signals changes with different MT concen-
tration both for rabbit and human MT (Fig. 5). Concentra-
tions of MT 0.025 and 0.05 mg/mL were analyzed.
With a lower concentration of rabbit MT, the Co2+ signal 
decreases and shifts to a less negative potential, whereas 
it slightly increases with a decreasing concentration of hu-
man MT (Fig. 5). Cat1 and Cat2 signals are more exposed 
in a lower concentration of MTs. With a lower rabbit MT 
concentration, Cat1 and Cat2 signals decreased and shifted 
to a more positive potential. These signals in the lower 
concentration of human MT had a negligible potential 
shift. The character of the mentioned MT signals changed 
with MTs concentrations. A lower concentration of MTs 
from both organisms coincided with a decrease in the Cat2 
signal. Lower, but more distinct signals were observed for 
human and rabbit MTs when a lower concentration was 
used (0.025 mg/mL). The same concentration of human 
MT gave higher Cat2 peak than rabbit MT. Metallothio-
neins isolated in both organisms behave differentially de-
spite the same number of –SH groups.
Conclusions
The structure of MTs is constantly being studied due 
to  their dynamic nature, lack of  secondary structural 
features when metals are not present, and the absence 
of spectroscopically active aromatic residues. Thus, dif-
ferent methods have been used for the analysis of human 
MT-1 and MT-2 isoforms and rabbit MT-2 isoforms.
Both in rabbit and human MTs, mainly monomers were 
detected with chip CE and MALDI-TOF-MS. Additionally, 
distinctly lower signals from the dimers were observed. 
When MALDI-TOF-MS is employed, the main observed 
signal for rabbit MT-2 corresponds to the mass of MT-2D. 
In human, MT-1A, MT-1G, MT-1G+Cd and MT-2A were 
detected. Metallothionein subisoforms, except in the case 
of human MT-1G+Cd, have been identified without metals, 
which can be due to the use of acidic matrixes that cause 
a release of less bound metals.
In the Brdicka reaction, signals are different for MTs 
isolated from rabbit and human liver, meaning that they 
behave differentially in electrochemistry despite the same 
Fig. 5. Metallothioneins (MTs) from rabbit and human liver analysis using the Brdicka reaction. Different concentrations of MT were used: 0.025 mg/mL and 
0.05 mg/mL.
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number of –SH groups. This may be due to different avail-
ability of MT cysteinyl groups in different organisms.
These methods used together allow for the identification 
and characterization of MT and give complementary infor-
mation about MT forms. Furthermore, MALDI-TOF-MS 
is capable of directly resolving more than just the main MT 
isoforms in the sample, which makes it the best of these 
techniques to identify isoforms of MT.
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